Physician profile
Jeffery Murphy
NPI 1770847907
$1,549.66
in general payments reported to CMS, 2019-2025
16 companies · $208 in 2025
The $208 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $599 · 2020: $94.22 · 2021: $22.48 · 2023: $260 · 2024: $367 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $834.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $834.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $459.93 | 2019-2025 | |
| Lilly USA, LLC | $253.18 | 2019-2024 | Jardiance, Mounjaro |
| Pfizer INC. | $245.94 | 2019-2025 | |
| Novo Nordisk INC | $137.90 | 2019-2025 | Ozempic, Rybelsus |
| Abbott Laboratories | $72.72 | 2023-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Astellas Pharma US INC | $68.34 | 2019-2020 | |
| Amgen INC. | $64.40 | 2019 | |
| Janssen Pharmaceuticals, INC | $43.61 | 2019 | |
| Merck Sharp & Dohme LLC | $43.28 | 2019-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Exact Sciences Corporation | $33.11 | 2024 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $31.14 | 2024 | Trelegy Ellipta |
| Amarin Pharma, INC. | $27.39 | 2019 | |
| Pulmonx Corporation | $22.48 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $17.89 | 2025 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.18 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $14.17 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffery Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.